chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Physical deconditioning, Pyrexia, Renal impairment, SARS-CoV-2 test positive, Sciatica
Clinical narrative: COVID Vaccine Breakthrough Case Pfizer Dose 1 3/12/21 (EN6205) Pfizer Dose 2 4/2/21 (EP7533) COVID Positive 12/3/21  12/3/21: Patient is a 71-year-old female with a past medical history significant for hypertension, hyperlipidemia, OSA, type 2 diabetes, CAD s/p CABG, pacemaker, history of CVA, chronic back pain.  The patient presents to the ED today with complaints of significant weakness.  The patient states over the last few weeks she has been significantly weak, completely losing her ability to ambulate as of yesterday.  The patient's accompanying symptoms include fever, chills, flank pain.  She states her accompanying symptoms began yesterday.  The patient denies any nausea, vomiting, chest pain or shortness of breath. She rates her flank pain 10/10 and describes it as stabbing despite receiving IV pain medications for management.  The patient is vaccinated against COVID-19.  The patient does have known chronic back pain with sciatica to her right leg.  She states however her lower back/flank pain is different from her chronic pain.  The patient denies any tobacco use, illicit drug abuse or alcohol abuse.     Of note, the patient was admitted to the facility on 10/26/2021 discharged on 11/03/2021 the patient was admitted due to confusion and to rule out stroke.  The patient was discharged to a rehabilitation facility for deconditioning.  The patient was discharged from rehabilitation facility on 11/11/2021 with PT/OT in her home.  The patient states she has been progressively weakening ever since then.  The patient admits to having 1 fall since being discharged from the rehab facility.   Upon arrival to ED patient's heart rate 61, respirations 16, pulse ox 97% on room air, blood pressure 130/64. Lumbar spine x-ray reveals severe degenerative changes in the lumbar spine including degenerative disc disease and facet arthropathy; the appearance of the spinous process would be compatible with Bastrop syndrome, degenerative listhesis in the lumbar spine.  Pelvic x-ray reveals no acute fractures. Patient's laboratory findings are significant for glucose 134, BUN 31, hemoglobin 10.1, hematocrit 34.4.  The patient received 1 Lortab, 2 mg IV morphine, 4 mg IV morphine, 750 mg IV Levaquin in ED.  12/13/21: 71-year-old woman who presented worsening generalized weakness, inability to ambulate.  Labs were suggestive of urinary tract infection, COVID-19 PCR was positive and renal function shows signs of dehydration.  She was admitted to the hospitalist service, IV rehydration was initiated, empiric antibiotic therapy for treatment of urinary tract infection was started with urine cultures subsequently yielding Klebsiella pneumoniae.  She was also found to be significantly physically deconditioned and recommended for skilled placement on discharge.  She remained stable from a respiratory perspective anti diabetic criteria for treatment of COVID-19 pneumonia throughout hospital course.  She has been accepted to rehab and his been discharged today in stable medical condition to continue rehabilitation.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The Moderna administered to the patient had an expiration date of 07/10/2022 but a Beyond Use Date of 05/07/2022.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Feeling abnormal, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: I had severe sore throat and foggy head on 5/16. I went to the urgent center and got tested for covid and was positive and had runny nose. But I'm doing really well. Also I had a family member who had covid at the time. I got my 4th dose/booster, two weeks ago.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had severe sore throat and foggy head on 5/16. I went to the urgent center and got tested for covid and was positive and had runny nose. But I'm doing really well. Also I had a family member who had covid at the time. I got my 4th dose/booster, two weeks ago.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Anticoagulant therapy, Asthenia, Back pain, COVID-19
Clinical narrative: COVID VAccine Breakthrough CAse  Moderna Dose 1 2/24/21 (013A21A) Moderna Dose 2 3/24/21 (003B21A) COVID Negative 11/20/21 COVID Positive 12/3/21  12/4/21: Patient is a pleasant 84-year-old female with past medical history multiple myeloma, back pain, history of PE, CKD stage IIIA, history of compression fracture T11 and L1 comes in with chief complaint fever weakness.  Patient is a poor historian history obtained from combination of chart review and ED provider sign-out.  Reportedly patient has been having weakness chronic back pain decreased functionality, and spiked fever of 102/103 as outpatient, family discussed with oncologist to recommended patient had to the emergency room for further evaluation.  Patient did received Tylenol prior to arrival.  On arrival in ED patient was afebrile. Chem panel without significant derangement, CBC improvement in leukopenia, was anemia with hemoglobin of 6.8 without any bleeding or bruising.  UA without pyuria, chest x-ray without acute derangement patient was well on room air.  ED administered 1 unit packed RBC, patient/family requesting possible placement. Request was made to admit patient to medical service for further treatment evaluation.  Patient seen evaluated at bedside lying comfortably in bed currently denies any lightheadedness, dizziness, vision change, no current chills or fever but has had episodes prior to arrival no shortness of breath chest pain palpitations abdominal pain, paresthesia or swelling of extremities.  Reports she does have periodic issues with urinary retention but no dysuria. Gets periodically constipated.  Denies any sick contacts or recent travel outside the area endorses compliance with medications.  Reportedly follows with oncologist.  Denies tobacco, alcohol, marijuana/recreational drug use, over-the-counter uses p.r.n. acetaminophen.  Family history otherwise reviewed and noncontributory to presenting problem.  Unclear on COVID-19 vaccination status booster with though documented received 2/2 earlier this year.  12/15/21: She will continue Lovenox injection at the nursing home for her history of PE.  Can be changed to oral anticoagulant NOAC, on discharge from skilled
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray normal, Chills, Condition aggravated, Constipation, Full blood count
Clinical narrative: COVID VAccine Breakthrough CAse  Moderna Dose 1 2/24/21 (013A21A) Moderna Dose 2 3/24/21 (003B21A) COVID Negative 11/20/21 COVID Positive 12/3/21  12/4/21: Patient is a pleasant 84-year-old female with past medical history multiple myeloma, back pain, history of PE, CKD stage IIIA, history of compression fracture T11 and L1 comes in with chief complaint fever weakness.  Patient is a poor historian history obtained from combination of chart review and ED provider sign-out.  Reportedly patient has been having weakness chronic back pain decreased functionality, and spiked fever of 102/103 as outpatient, family discussed with oncologist to recommended patient had to the emergency room for further evaluation.  Patient did received Tylenol prior to arrival.  On arrival in ED patient was afebrile. Chem panel without significant derangement, CBC improvement in leukopenia, was anemia with hemoglobin of 6.8 without any bleeding or bruising.  UA without pyuria, chest x-ray without acute derangement patient was well on room air.  ED administered 1 unit packed RBC, patient/family requesting possible placement. Request was made to admit patient to medical service for further treatment evaluation.  Patient seen evaluated at bedside lying comfortably in bed currently denies any lightheadedness, dizziness, vision change, no current chills or fever but has had episodes prior to arrival no shortness of breath chest pain palpitations abdominal pain, paresthesia or swelling of extremities.  Reports she does have periodic issues with urinary retention but no dysuria. Gets periodically constipated.  Denies any sick contacts or recent travel outside the area endorses compliance with medications.  Reportedly follows with oncologist.  Denies tobacco, alcohol, marijuana/recreational drug use, over-the-counter uses p.r.n. acetaminophen.  Family history otherwise reviewed and noncontributory to presenting problem.  Unclear on COVID-19 vaccination status booster with though documented received 2/2 earlier this year.  12/15/21: She will continue Lovenox injection at the nursing home for her history of PE.  Can be changed to oral anticoagulant NOAC, on discharge from skilled
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Leukopenia, Pyrexia, Red blood cell transfusion, SARS-CoV-2 test positive
Clinical narrative: COVID VAccine Breakthrough CAse  Moderna Dose 1 2/24/21 (013A21A) Moderna Dose 2 3/24/21 (003B21A) COVID Negative 11/20/21 COVID Positive 12/3/21  12/4/21: Patient is a pleasant 84-year-old female with past medical history multiple myeloma, back pain, history of PE, CKD stage IIIA, history of compression fracture T11 and L1 comes in with chief complaint fever weakness.  Patient is a poor historian history obtained from combination of chart review and ED provider sign-out.  Reportedly patient has been having weakness chronic back pain decreased functionality, and spiked fever of 102/103 as outpatient, family discussed with oncologist to recommended patient had to the emergency room for further evaluation.  Patient did received Tylenol prior to arrival.  On arrival in ED patient was afebrile. Chem panel without significant derangement, CBC improvement in leukopenia, was anemia with hemoglobin of 6.8 without any bleeding or bruising.  UA without pyuria, chest x-ray without acute derangement patient was well on room air.  ED administered 1 unit packed RBC, patient/family requesting possible placement. Request was made to admit patient to medical service for further treatment evaluation.  Patient seen evaluated at bedside lying comfortably in bed currently denies any lightheadedness, dizziness, vision change, no current chills or fever but has had episodes prior to arrival no shortness of breath chest pain palpitations abdominal pain, paresthesia or swelling of extremities.  Reports she does have periodic issues with urinary retention but no dysuria. Gets periodically constipated.  Denies any sick contacts or recent travel outside the area endorses compliance with medications.  Reportedly follows with oncologist.  Denies tobacco, alcohol, marijuana/recreational drug use, over-the-counter uses p.r.n. acetaminophen.  Family history otherwise reviewed and noncontributory to presenting problem.  Unclear on COVID-19 vaccination status booster with though documented received 2/2 earlier this year.  12/15/21: She will continue Lovenox injection at the nursing home for her history of PE.  Can be changed to oral anticoagulant NOAC, on discharge from skilled
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary retention, Urine analysis normal, Vaccine breakthrough infection
Clinical narrative: COVID VAccine Breakthrough CAse  Moderna Dose 1 2/24/21 (013A21A) Moderna Dose 2 3/24/21 (003B21A) COVID Negative 11/20/21 COVID Positive 12/3/21  12/4/21: Patient is a pleasant 84-year-old female with past medical history multiple myeloma, back pain, history of PE, CKD stage IIIA, history of compression fracture T11 and L1 comes in with chief complaint fever weakness.  Patient is a poor historian history obtained from combination of chart review and ED provider sign-out.  Reportedly patient has been having weakness chronic back pain decreased functionality, and spiked fever of 102/103 as outpatient, family discussed with oncologist to recommended patient had to the emergency room for further evaluation.  Patient did received Tylenol prior to arrival.  On arrival in ED patient was afebrile. Chem panel without significant derangement, CBC improvement in leukopenia, was anemia with hemoglobin of 6.8 without any bleeding or bruising.  UA without pyuria, chest x-ray without acute derangement patient was well on room air.  ED administered 1 unit packed RBC, patient/family requesting possible placement. Request was made to admit patient to medical service for further treatment evaluation.  Patient seen evaluated at bedside lying comfortably in bed currently denies any lightheadedness, dizziness, vision change, no current chills or fever but has had episodes prior to arrival no shortness of breath chest pain palpitations abdominal pain, paresthesia or swelling of extremities.  Reports she does have periodic issues with urinary retention but no dysuria. Gets periodically constipated.  Denies any sick contacts or recent travel outside the area endorses compliance with medications.  Reportedly follows with oncologist.  Denies tobacco, alcohol, marijuana/recreational drug use, over-the-counter uses p.r.n. acetaminophen.  Family history otherwise reviewed and noncontributory to presenting problem.  Unclear on COVID-19 vaccination status booster with though documented received 2/2 earlier this year.  12/15/21: She will continue Lovenox injection at the nursing home for her history of PE.  Can be changed to oral anticoagulant NOAC, on discharge from skilled
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium decreased, Body temperature increased, COVID-19, Dyspnoea, Feeling cold
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 4/18/21 COVID Positive 12/10/21  12/10/21: Patient is a 61-year-old male with past medical history of tobacco use and alcohol use.  He presented on 12/10/2021 with chief complaint of shortness of breath. His symptoms had been present for approximately 1 week and gradually worsened until today when he felt he needed to be evaluated.  He previously received 1 dose of the COVID-19 vaccine approximately 6 months ago.  He did not return for his 2nd dose.  He feels cold and sweaty, but otherwise denies chest pain, pain in his lower extremities, abdominal pain, nausea, vomiting.  He smokes 1.5 packs of cigarettes per day and has done so throughout his adult life.  He states that he has drank a six-pack of beer per day for the last 50 years.  He denies taking any medications at home regularly.  He does note that he has been told he has high blood pressure in the past.  He is unaware of any other medical problems.       Family history is noncontributory. In the emergency department, the patient was febrile with a temperature of 103.2° F. He was also tachycardic, tachypneic, and hypoxic requiring supplemental oxygen.  Lab work notable for COVID-19 positive.  Sodium was 131. WBC 14.21.  Patient was administered DuoNeb, LR, Solu-Medrol, Zosyn.  12/14/21: Patient was admitted and started on ceftriaxone, azithromycin, remdesivir, and Decadron.  Was also started on bronchodilators for underlying COPD which was not treated.  He was given nicotine patch for nicotine withdrawal.  He was monitored on CIWA protocol and scores remained low.  Patient initially required 4 L of oxygen which was able to be titrated down to 2 L quickly.  He remained afebrile after admission.  A home oxygen evaluation was performed on the day of discharge which showed he needed no oxygen at rest or with exertion.  Will discharge patient on 5 further days of Decadron 6 mg daily along with albuterol, Breo, and Incruse.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Hypoxia, Incomplete course of vaccination, Laboratory test abnormal, SARS-CoV-2 test positive
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 4/18/21 COVID Positive 12/10/21  12/10/21: Patient is a 61-year-old male with past medical history of tobacco use and alcohol use.  He presented on 12/10/2021 with chief complaint of shortness of breath. His symptoms had been present for approximately 1 week and gradually worsened until today when he felt he needed to be evaluated.  He previously received 1 dose of the COVID-19 vaccine approximately 6 months ago.  He did not return for his 2nd dose.  He feels cold and sweaty, but otherwise denies chest pain, pain in his lower extremities, abdominal pain, nausea, vomiting.  He smokes 1.5 packs of cigarettes per day and has done so throughout his adult life.  He states that he has drank a six-pack of beer per day for the last 50 years.  He denies taking any medications at home regularly.  He does note that he has been told he has high blood pressure in the past.  He is unaware of any other medical problems.       Family history is noncontributory. In the emergency department, the patient was febrile with a temperature of 103.2° F. He was also tachycardic, tachypneic, and hypoxic requiring supplemental oxygen.  Lab work notable for COVID-19 positive.  Sodium was 131. WBC 14.21.  Patient was administered DuoNeb, LR, Solu-Medrol, Zosyn.  12/14/21: Patient was admitted and started on ceftriaxone, azithromycin, remdesivir, and Decadron.  Was also started on bronchodilators for underlying COPD which was not treated.  He was given nicotine patch for nicotine withdrawal.  He was monitored on CIWA protocol and scores remained low.  Patient initially required 4 L of oxygen which was able to be titrated down to 2 L quickly.  He remained afebrile after admission.  A home oxygen evaluation was performed on the day of discharge which showed he needed no oxygen at rest or with exertion.  Will discharge patient on 5 further days of Decadron 6 mg daily along with albuterol, Breo, and Incruse.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia, Tachypnoea, Vaccine breakthrough infection, White blood cell count increased
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 4/18/21 COVID Positive 12/10/21  12/10/21: Patient is a 61-year-old male with past medical history of tobacco use and alcohol use.  He presented on 12/10/2021 with chief complaint of shortness of breath. His symptoms had been present for approximately 1 week and gradually worsened until today when he felt he needed to be evaluated.  He previously received 1 dose of the COVID-19 vaccine approximately 6 months ago.  He did not return for his 2nd dose.  He feels cold and sweaty, but otherwise denies chest pain, pain in his lower extremities, abdominal pain, nausea, vomiting.  He smokes 1.5 packs of cigarettes per day and has done so throughout his adult life.  He states that he has drank a six-pack of beer per day for the last 50 years.  He denies taking any medications at home regularly.  He does note that he has been told he has high blood pressure in the past.  He is unaware of any other medical problems.       Family history is noncontributory. In the emergency department, the patient was febrile with a temperature of 103.2° F. He was also tachycardic, tachypneic, and hypoxic requiring supplemental oxygen.  Lab work notable for COVID-19 positive.  Sodium was 131. WBC 14.21.  Patient was administered DuoNeb, LR, Solu-Medrol, Zosyn.  12/14/21: Patient was admitted and started on ceftriaxone, azithromycin, remdesivir, and Decadron.  Was also started on bronchodilators for underlying COPD which was not treated.  He was given nicotine patch for nicotine withdrawal.  He was monitored on CIWA protocol and scores remained low.  Patient initially required 4 L of oxygen which was able to be titrated down to 2 L quickly.  He remained afebrile after admission.  A home oxygen evaluation was performed on the day of discharge which showed he needed no oxygen at rest or with exertion.  Will discharge patient on 5 further days of Decadron 6 mg daily along with albuterol, Breo, and Incruse.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Hysterectomy, Lymphadenectomy, Postmenopausal haemorrhage, Robotic surgery, Ultrasound scan vagina abnormal
Clinical narrative: I received the vaccine 05/17/2021. The next day I began bleeding vaginally. I bled for about 3-4 days and then it stopped like I was having my menstrual. I started bleeding again in Aug and that lasted until December continuously. In Nov 2021 I had a vaginal probe ultrasound. Now in March 9,2022 I underwent a DNC. Showed I had cancer. On May 3 2022 I had a robotic hysterectomy. During hysterotomy they remove 4 sentinel lymph nodes. Cancer was stage 1A and did not spread into lymph nodes. Tumor was 2.2 cn.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Uterine cancer, Uterine dilation and curettage, Uterine mass
Clinical narrative: I received the vaccine 05/17/2021. The next day I began bleeding vaginally. I bled for about 3-4 days and then it stopped like I was having my menstrual. I started bleeding again in Aug and that lasted until December continuously. In Nov 2021 I had a vaginal probe ultrasound. Now in March 9,2022 I underwent a DNC. Showed I had cancer. On May 3 2022 I had a robotic hysterectomy. During hysterotomy they remove 4 sentinel lymph nodes. Cancer was stage 1A and did not spread into lymph nodes. Tumor was 2.2 cn.
Age: 21.0
Sex: F
Vaccine: PPV
Symptoms: Cough, Pharyngeal swelling
Clinical narrative: Throat swelling and coughing within 1 minute of receiving Pneumovax 23. Patient received epinephrine, oxygen and sent to emergency department.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was  refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F. However, that is not approved by State o for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Cough, Fatigue, Feeling abnormal
Clinical narrative: 04/04/2022 Vaccination; 05/06/2022 I had lots of fatigue, weakness and very bad HA. COVID; +; I went to urgent care that day, started Paxlovid. By end of that course, I was symptom free. Antigen testing was getting lighter. By 05/14/2022 it was negative. 05/17/2022 I was feeling lousy again; cough and running nose, fatigue. Retested; COVID+; Presently still have some residual symptoms; COVID x2.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Headache, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: 04/04/2022 Vaccination; 05/06/2022 I had lots of fatigue, weakness and very bad HA. COVID; +; I went to urgent care that day, started Paxlovid. By end of that course, I was symptom free. Antigen testing was getting lighter. By 05/14/2022 it was negative. 05/17/2022 I was feeling lousy again; cough and running nose, fatigue. Retested; COVID+; Presently still have some residual symptoms; COVID x2.
Age: 61.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: 04/04/2022 Vaccination; 05/06/2022 I had lots of fatigue, weakness and very bad HA. COVID; +; I went to urgent care that day, started Paxlovid. By end of that course, I was symptom free. Antigen testing was getting lighter. By 05/14/2022 it was negative. 05/17/2022 I was feeling lousy again; cough and running nose, fatigue. Retested; COVID+; Presently still have some residual symptoms; COVID x2.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Attention deficit hyperactivity disorder, Borrelia test, Butterfly rash, Condition aggravated, Ear pain
Clinical narrative: On 5/12/21 (one day after first vaccine) I got a bullseye rash on my face.  First test for lyme was positive, but no tick was found. Subsequent tests for lyme were inconclusive. I completed doxycycline treatment for Lyme. In July, I started suffering from migraines and fatigue. I also experienced an increase in ADHD symptoms despite being on medication that had been effective for 5+ years. I sought treatment from my infectious disease doctor(thinking it was lyme related and he assured me it wasn't) who suggested I try antihistamines as I had fluid in my inner ear. I tried antihistamines with no success.  I went to my  my primary care doctor about the headaches and earaches, who referred me to a neurologist. After my November vaccine, I got another malar rash. The rash and inconclusive neurological testing led my neurologist to refer me to a rheumatologist. No autoimmune issues were found, but given the pattern of autoimmune symptoms after the vaccine, the rheumatologist mentioned she has seen quite a few patients who had strong immune responses to the vaccine that mimicked autoimmune disease.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Headache, Middle ear effusion, Migraine, Rash
Clinical narrative: On 5/12/21 (one day after first vaccine) I got a bullseye rash on my face.  First test for lyme was positive, but no tick was found. Subsequent tests for lyme were inconclusive. I completed doxycycline treatment for Lyme. In July, I started suffering from migraines and fatigue. I also experienced an increase in ADHD symptoms despite being on medication that had been effective for 5+ years. I sought treatment from my infectious disease doctor(thinking it was lyme related and he assured me it wasn't) who suggested I try antihistamines as I had fluid in my inner ear. I tried antihistamines with no success.  I went to my  my primary care doctor about the headaches and earaches, who referred me to a neurologist. After my November vaccine, I got another malar rash. The rash and inconclusive neurological testing led my neurologist to refer me to a rheumatologist. No autoimmune issues were found, but given the pattern of autoimmune symptoms after the vaccine, the rheumatologist mentioned she has seen quite a few patients who had strong immune responses to the vaccine that mimicked autoimmune disease.
Age: 10.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The vaccine given was expired. It's expiration date was 5/9/22 and the vaccine was administered on 5/18/22. The patient's guardian was contacted.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Hyperhidrosis, Pallor, Syncope
Clinical narrative: Shortly after patient received all 3 vaccines she fainted for approximately 5-10 seconds.  After she regained consciousness she was talking and laughing.  She was pale and sweaty.  She recovered and felt back to normal within 10 minutes, no further issues.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Feeling abnormal, Malaise, Pyrexia, Respiratory tract congestion
Clinical narrative: I took my first flight in 2 years and I always seem to get sick afterwards. When I got back Sunday night, I didn't feel great. By Monday, I felt sick. I took an at home test on Tuesday and it was negative. I made an appointment for the minute clinic for Thursday (05/19/2022) and was tested and it was Positive for COVID. I have had congestion and a constant runny nose for 2 days. On Wednesday, I started taking Mucinex FastMax. I have taken Mucinex night time and Advil PM at bedtime. I feel a little out of it from the congestion today but that's it. I no longer have a fever and, I contacted my PCP, who recommended Paxlovid. However, she requested a video visit to discuss it but her only availability was a week out which is outside the recommended time to use Paxlovid. So I messaged her and am waiting for a response. I did not have a fever Monday but I had one Tuesday for about 2 hours and haven't had one since.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I took my first flight in 2 years and I always seem to get sick afterwards. When I got back Sunday night, I didn't feel great. By Monday, I felt sick. I took an at home test on Tuesday and it was negative. I made an appointment for the minute clinic for Thursday (05/19/2022) and was tested and it was Positive for COVID. I have had congestion and a constant runny nose for 2 days. On Wednesday, I started taking Mucinex FastMax. I have taken Mucinex night time and Advil PM at bedtime. I feel a little out of it from the congestion today but that's it. I no longer have a fever and, I contacted my PCP, who recommended Paxlovid. However, she requested a video visit to discuss it but her only availability was a week out which is outside the recommended time to use Paxlovid. So I messaged her and am waiting for a response. I did not have a fever Monday but I had one Tuesday for about 2 hours and haven't had one since.
Age: 29.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 27.0
Sex: U
Vaccine: COVID19
Symptoms: No adverse event, Product storage error
Clinical narrative: On the clinic day, the vaccine was transported out from the pharmacy to the facility without a digital data logger. The packing used for transport was a refrigerated packaging tote to maintain a temperature of 36 F - 46 F.  However, that is not approved by State for COVID-19 vaccine transportation. The total time (from when vaccine left the pharmacy to the clinic completion) was less than 6 hours. There were no adverse events.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dysphagia, Dysphonia, Dyspnoea, Dyspnoea exertional
Clinical narrative: I contracted COVID-10 on 5/15/2022 with symptoms of sore throat, trouble swallowing, fever of 101.3 at highest point, fatigue, myalgia, elevated heart rate, pulse ox levels got a bit low, and shortness of breath with an movement or activity. I was prescribed Paxlovid 05/17/2022 and was told they were not doing monoclonal antibodies anymore. I am still experiencing fever, fatigue, hoarse voice from a prolonged sore throat, and the shortness of breath has improved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Heart rate increased, Myalgia, Oropharyngeal pain, Oxygen saturation decreased
Clinical narrative: I contracted COVID-10 on 5/15/2022 with symptoms of sore throat, trouble swallowing, fever of 101.3 at highest point, fatigue, myalgia, elevated heart rate, pulse ox levels got a bit low, and shortness of breath with an movement or activity. I was prescribed Paxlovid 05/17/2022 and was told they were not doing monoclonal antibodies anymore. I am still experiencing fever, fatigue, hoarse voice from a prolonged sore throat, and the shortness of breath has improved.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive
Clinical narrative: I contracted COVID-10 on 5/15/2022 with symptoms of sore throat, trouble swallowing, fever of 101.3 at highest point, fatigue, myalgia, elevated heart rate, pulse ox levels got a bit low, and shortness of breath with an movement or activity. I was prescribed Paxlovid 05/17/2022 and was told they were not doing monoclonal antibodies anymore. I am still experiencing fever, fatigue, hoarse voice from a prolonged sore throat, and the shortness of breath has improved.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Chest pain, Chronic obstructive pulmonary disease, Condition aggravated, Fibrin D dimer increased
Clinical narrative: COVID VAccine Breakthrough Case  J&J Dose 10/28/21 (1822809) COVID Positive sometime Nov 2021  12/4/21: 64-year-old female with PMH of recent COVID-19 infection and right pulmonary embolism diagnosed at a HCF, chronic hypoxic respiratory failure on 2 L, COPD, possible lung cancer follows up with Dr., depression, who was discharged from the hospital on December 2, 2021 after being treated for pneumonia with moderate loculated right pleural effusion, and COPD exacerbation.  She presented to ER again with a complaint of sudden onset severe right-sided sharp CP that is constant, worsens with breathing.  That is the only new symptom since discharge, otherwise denied any other complaints.  Patient is an ex-smoker, denies alcohol use, no recreational drug use.   During last admission pulmonology were consulted, patient received treatment for COPD exacerbation including steroids in nebulizer treatments.  Oxygen level were about baseline around 2 L, she finished Levaquin for pneumonia. Pulmonology were consulted in thought effusion is minimal to be aspirated.  Right lower lung had masslike lesions but plan was to have her follow-up with her oncologist for possible PET scan.   In ED, oxygen 5 L by nasal cannula.  No fever, no significant change in lab work including chronic leukopenia.  Due to sudden onset right sided chest pain and elevated D-dimer CT angiogram of the chest was ordered however does official read is up yet.  12/10/21: Patient was admited and was given COVID 19 treatment initially with remdesivir and decadron. Given her COVID positiivty status in October, it is likely the positive PCR is a reflection of recent COVID infection instead of a true acute new re-infection. She was given O2 supplement and her requirement stays around her baseline needs. Pt is up ad lib in room. The initial plan was to have her go back to a facility however insurance denied coverage despite the peer to peer discussion. She underwent O2 walk test and needs 3L with rest and 5L with activity. She is discharged home to complete a few more days of PO steroids. She is discharged in hemodynamically stable conditions. Total time spent on d/c 40 min
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Leukopenia, Painful respiration, Pleural effusion, Pneumonia
Clinical narrative: COVID VAccine Breakthrough Case  J&J Dose 10/28/21 (1822809) COVID Positive sometime Nov 2021  12/4/21: 64-year-old female with PMH of recent COVID-19 infection and right pulmonary embolism diagnosed at a HCF, chronic hypoxic respiratory failure on 2 L, COPD, possible lung cancer follows up with Dr., depression, who was discharged from the hospital on December 2, 2021 after being treated for pneumonia with moderate loculated right pleural effusion, and COPD exacerbation.  She presented to ER again with a complaint of sudden onset severe right-sided sharp CP that is constant, worsens with breathing.  That is the only new symptom since discharge, otherwise denied any other complaints.  Patient is an ex-smoker, denies alcohol use, no recreational drug use.   During last admission pulmonology were consulted, patient received treatment for COPD exacerbation including steroids in nebulizer treatments.  Oxygen level were about baseline around 2 L, she finished Levaquin for pneumonia. Pulmonology were consulted in thought effusion is minimal to be aspirated.  Right lower lung had masslike lesions but plan was to have her follow-up with her oncologist for possible PET scan.   In ED, oxygen 5 L by nasal cannula.  No fever, no significant change in lab work including chronic leukopenia.  Due to sudden onset right sided chest pain and elevated D-dimer CT angiogram of the chest was ordered however does official read is up yet.  12/10/21: Patient was admited and was given COVID 19 treatment initially with remdesivir and decadron. Given her COVID positiivty status in October, it is likely the positive PCR is a reflection of recent COVID infection instead of a true acute new re-infection. She was given O2 supplement and her requirement stays around her baseline needs. Pt is up ad lib in room. The initial plan was to have her go back to a facility however insurance denied coverage despite the peer to peer discussion. She underwent O2 walk test and needs 3L with rest and 5L with activity. She is discharged home to complete a few more days of PO steroids. She is discharged in hemodynamically stable conditions. Total time spent on d/c 40 min
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pulmonary mass, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID VAccine Breakthrough Case  J&J Dose 10/28/21 (1822809) COVID Positive sometime Nov 2021  12/4/21: 64-year-old female with PMH of recent COVID-19 infection and right pulmonary embolism diagnosed at a HCF, chronic hypoxic respiratory failure on 2 L, COPD, possible lung cancer follows up with Dr., depression, who was discharged from the hospital on December 2, 2021 after being treated for pneumonia with moderate loculated right pleural effusion, and COPD exacerbation.  She presented to ER again with a complaint of sudden onset severe right-sided sharp CP that is constant, worsens with breathing.  That is the only new symptom since discharge, otherwise denied any other complaints.  Patient is an ex-smoker, denies alcohol use, no recreational drug use.   During last admission pulmonology were consulted, patient received treatment for COPD exacerbation including steroids in nebulizer treatments.  Oxygen level were about baseline around 2 L, she finished Levaquin for pneumonia. Pulmonology were consulted in thought effusion is minimal to be aspirated.  Right lower lung had masslike lesions but plan was to have her follow-up with her oncologist for possible PET scan.   In ED, oxygen 5 L by nasal cannula.  No fever, no significant change in lab work including chronic leukopenia.  Due to sudden onset right sided chest pain and elevated D-dimer CT angiogram of the chest was ordered however does official read is up yet.  12/10/21: Patient was admited and was given COVID 19 treatment initially with remdesivir and decadron. Given her COVID positiivty status in October, it is likely the positive PCR is a reflection of recent COVID infection instead of a true acute new re-infection. She was given O2 supplement and her requirement stays around her baseline needs. Pt is up ad lib in room. The initial plan was to have her go back to a facility however insurance denied coverage despite the peer to peer discussion. She underwent O2 walk test and needs 3L with rest and 5L with activity. She is discharged home to complete a few more days of PO steroids. She is discharged in hemodynamically stable conditions. Total time spent on d/c 40 min
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute respiratory failure, Aspergillus test positive, Asthenia, COVID-19, COVID-19 pneumonia
Clinical narrative: COVID VAccine Breakthrough Case  J&J Dose 10/28/21 (1822809) COVID Positive sometime Nov 2021  12/4/21: 64-year-old female with PMH of recent COVID-19 infection and right pulmonary embolism diagnosed at a HCF, chronic hypoxic respiratory failure on 2 L, COPD, possible lung cancer follows up with Dr., depression, who was discharged from the hospital on December 2, 2021 after being treated for pneumonia with moderate loculated right pleural effusion, and COPD exacerbation.  She presented to ER again with a complaint of sudden onset severe right-sided sharp CP that is constant, worsens with breathing.  That is the only new symptom since discharge, otherwise denied any other complaints.  Patient is an ex-smoker, denies alcohol use, no recreational drug use.   During last admission pulmonology were consulted, patient received treatment for COPD exacerbation including steroids in nebulizer treatments.  Oxygen level were about baseline around 2 L, she finished Levaquin for pneumonia. Pulmonology were consulted in thought effusion is minimal to be aspirated.  Right lower lung had masslike lesions but plan was to have her follow-up with her oncologist for possible PET scan.   In ED, oxygen 5 L by nasal cannula.  No fever, no significant change in lab work including chronic leukopenia.  Due to sudden onset right sided chest pain and elevated D-dimer CT angiogram of the chest was ordered however does official read is up yet.  12/10/21: Patient was admited and was given COVID 19 treatment initially with remdesivir and decadron. Given her COVID positiivty status in October, it is likely the positive PCR is a reflection of recent COVID infection instead of a true acute new re-infection. She was given O2 supplement and her requirement stays around her baseline needs. Pt is up ad lib in room. The initial plan was to have her go back to a facility however insurance denied coverage despite the peer to peer discussion. She underwent O2 walk test and needs 3L with rest and 5L with activity. She is discharged home to complete a few more days of PO steroids. She is discharged in hemodynamically stable conditions. Total time spent on d/c 40 min
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Chronic obstructive pulmonary disease, Computerised tomogram thorax abnormal, Condition aggravated, Deep vein thrombosis
Clinical narrative: COVID VAccine Breakthrough Case  J&J Dose 10/28/21 (1822809) COVID Positive sometime Nov 2021  12/4/21: 64-year-old female with PMH of recent COVID-19 infection and right pulmonary embolism diagnosed at a HCF, chronic hypoxic respiratory failure on 2 L, COPD, possible lung cancer follows up with Dr., depression, who was discharged from the hospital on December 2, 2021 after being treated for pneumonia with moderate loculated right pleural effusion, and COPD exacerbation.  She presented to ER again with a complaint of sudden onset severe right-sided sharp CP that is constant, worsens with breathing.  That is the only new symptom since discharge, otherwise denied any other complaints.  Patient is an ex-smoker, denies alcohol use, no recreational drug use.   During last admission pulmonology were consulted, patient received treatment for COPD exacerbation including steroids in nebulizer treatments.  Oxygen level were about baseline around 2 L, she finished Levaquin for pneumonia. Pulmonology were consulted in thought effusion is minimal to be aspirated.  Right lower lung had masslike lesions but plan was to have her follow-up with her oncologist for possible PET scan.   In ED, oxygen 5 L by nasal cannula.  No fever, no significant change in lab work including chronic leukopenia.  Due to sudden onset right sided chest pain and elevated D-dimer CT angiogram of the chest was ordered however does official read is up yet.  12/10/21: Patient was admited and was given COVID 19 treatment initially with remdesivir and decadron. Given her COVID positiivty status in October, it is likely the positive PCR is a reflection of recent COVID infection instead of a true acute new re-infection. She was given O2 supplement and her requirement stays around her baseline needs. Pt is up ad lib in room. The initial plan was to have her go back to a facility however insurance denied coverage despite the peer to peer discussion. She underwent O2 walk test and needs 3L with rest and 5L with activity. She is discharged home to complete a few more days of PO steroids. She is discharged in hemodynamically stable conditions. Total time spent on d/c 40 min
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Dyspnoea exertional, Ex-tobacco user, Fatigue, Full blood count normal
Clinical narrative: COVID VAccine Breakthrough Case  J&J Dose 10/28/21 (1822809) COVID Positive sometime Nov 2021  12/4/21: 64-year-old female with PMH of recent COVID-19 infection and right pulmonary embolism diagnosed at a HCF, chronic hypoxic respiratory failure on 2 L, COPD, possible lung cancer follows up with Dr., depression, who was discharged from the hospital on December 2, 2021 after being treated for pneumonia with moderate loculated right pleural effusion, and COPD exacerbation.  She presented to ER again with a complaint of sudden onset severe right-sided sharp CP that is constant, worsens with breathing.  That is the only new symptom since discharge, otherwise denied any other complaints.  Patient is an ex-smoker, denies alcohol use, no recreational drug use.   During last admission pulmonology were consulted, patient received treatment for COPD exacerbation including steroids in nebulizer treatments.  Oxygen level were about baseline around 2 L, she finished Levaquin for pneumonia. Pulmonology were consulted in thought effusion is minimal to be aspirated.  Right lower lung had masslike lesions but plan was to have her follow-up with her oncologist for possible PET scan.   In ED, oxygen 5 L by nasal cannula.  No fever, no significant change in lab work including chronic leukopenia.  Due to sudden onset right sided chest pain and elevated D-dimer CT angiogram of the chest was ordered however does official read is up yet.  12/10/21: Patient was admited and was given COVID 19 treatment initially with remdesivir and decadron. Given her COVID positiivty status in October, it is likely the positive PCR is a reflection of recent COVID infection instead of a true acute new re-infection. She was given O2 supplement and her requirement stays around her baseline needs. Pt is up ad lib in room. The initial plan was to have her go back to a facility however insurance denied coverage despite the peer to peer discussion. She underwent O2 walk test and needs 3L with rest and 5L with activity. She is discharged home to complete a few more days of PO steroids. She is discharged in hemodynamically stable conditions. Total time spent on d/c 40 min